title: Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University, 300 Pasteur Drive, Grant Building Room H307A, Stanford, CA, 94305, USA. mjbutte@stanford.edu.
authors.forename: Manish J
authors.initials: MJ
authors.lastname: Butte
authors.affiliation: Division of Gastroenterology, Department of Pediatrics, Stanford University, Stanford, CA, USA.
authors.forename: K T
authors.initials: KT
authors.lastname: Park
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University, 300 Pasteur Drive, Grant Building Room H307A, Stanford, CA, 94305, USA.
authors.forename: David B
authors.initials: DB
authors.lastname: Lewis
mesh_terms: D000293:Adolescent; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology; D006105:Granulomatous Disease, Chronic / Q000150:complications*; D006801:Humans; D018664:Interleukin-12 / Q000037:antagonists & inhibitors; D053759:Interleukin-23 / Q000037:antagonists & inhibitors; D008297:Male; D000069549:Ustekinumab / Q000627:therapeutic use*
chemical_list: D053759:Interleukin-23; D018664:Interleukin-12; D000069549:Ustekinumab